343 related articles for article (PubMed ID: 35309364)
1. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
2. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
3. The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis.
Singh Kakan S; Li X; Edman MC; Okamoto CT; Hjelm BE; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):1. PubMed ID: 37010857
[TBL] [Abstract][Full Text] [Related]
4. Small RNA Deep Sequencing Identifies a Unique miRNA Signature Released in Serum Exosomes in a Mouse Model of Sjögren's Syndrome.
Kakan SS; Janga SR; Cooperman B; Craig DW; Edman MC; Okamoto CT; Hamm-Alvarez SF
Front Immunol; 2020; 11():1475. PubMed ID: 32849505
[TBL] [Abstract][Full Text] [Related]
5. Comparison of MicroRNA Expression in Tears of Normal Subjects and Sjögren Syndrome Patients.
Kim YJ; Yeon Y; Lee WJ; Shin YU; Cho H; Sung YK; Kim DR; Lim HW; Kang MH
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4889-4895. PubMed ID: 31752018
[TBL] [Abstract][Full Text] [Related]
6. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
7. Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren's Syndrome Patients.
Castro I; Carvajal P; Jara D; Aguilera S; Heathcote B; Barrera MJ; Aliaga-Tobar V; Maracaja-Coutinho V; Urzúa U; Quest AFG; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2022; 13():870094. PubMed ID: 35432384
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
10. hsa-miR-424-5p and hsa-miR-513c-3p dysregulation mediated by IFN-γ is associated with salivary gland dysfunction in Sjögren's syndrome patients.
Carvajal P; Aguilera S; Jara D; Indo S; Barrera MJ; González S; Molina C; Heathcote B; Hermoso M; Castro I; González MJ
J Autoimmun; 2023 Jul; 138():103037. PubMed ID: 37229808
[TBL] [Abstract][Full Text] [Related]
11. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.
Li L; Jasmer KJ; Camden JM; Woods LT; Martin AL; Yang Y; Layton M; Petris MJ; Baker OJ; Weisman GA; Petris CK
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):18. PubMed ID: 35727180
[TBL] [Abstract][Full Text] [Related]
12. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
Jara D; Carvajal P; Castro I; Barrera MJ; Aguilera S; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2021; 12():685837. PubMed ID: 34149728
[TBL] [Abstract][Full Text] [Related]
13. Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients.
Edman MC; Janga SR; Meng Z; Bechtold M; Chen AF; Kim C; Naman L; Sarma A; Teekappanavar N; Kim AY; Madrigal S; Singh S; Ortiz E; Christianakis S; Arkfeld DG; Mack WJ; Heur M; Stohl W; Hamm-Alvarez SF
Sci Rep; 2018 Jul; 8(1):11044. PubMed ID: 30038391
[TBL] [Abstract][Full Text] [Related]
14. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren's syndrome-associated dry eye.
Zhou L; Wei R; Zhao P; Koh SK; Beuerman RW; Ding C
Proteomics; 2013 Aug; 13(16):2469-81. PubMed ID: 23733261
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
[TBL] [Abstract][Full Text] [Related]
18. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
20. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
